Immodulon adopts AI tool to accelerate pancreatic cancer clinical trial 30-Jul-2019 By Vassia Barba Immodulon to utilize biomarkers identified by Biodesix’ machine learning platform, aiming to accelerate the clinical development of its pancreatic treatment.